Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

330 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 330 results

Post-approval studies (Phase 4)Study completedNCT00806234
What this trial is testing

Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics

Who this might be right for
Psychotic Disorders
Johns Hopkins University 127
Early research (Phase 1)Study completedNCT02501109
What this trial is testing

Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

Who this might be right for
Schizophrenia
CMG Pharmaceutical Co. Ltd 36
Post-approval studies (Phase 4)Study completedNCT00634348
What this trial is testing

A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 256
Post-approval studies (Phase 4)Study completedNCT00392197
What this trial is testing

Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd. 111
Early research (Phase 1)Study completedNCT00362271
What this trial is testing

Aripiprazole and Effexor XR Drug Interaction Study

Who this might be right for
Healthy
Otsuka Pharmaceutical Development & Commercialization, Inc. 38
Post-approval studies (Phase 4)UnknownNCT01742390
What this trial is testing

Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Who this might be right for
Sexual DysfunctionHyperprolactinemia
Si Tianmei 120
Early research (Phase 1)Study completedNCT02087579
What this trial is testing

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Who this might be right for
Psychotic DisordersSchizophreniaBipolar Disorder+1 more
Janssen Research & Development, LLC 305
Post-approval studies (Phase 4)UnknownNCT03881449
What this trial is testing

DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole

Who this might be right for
SchizophreniaMajor Depressive DisorderBi-Polar Disorder+1 more
Durham VA Medical Center 46
Not applicableStudy completedNCT02191358
What this trial is testing

YouScript IMPACT Registry

Who this might be right for
Adverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more
Genelex Corporation 800
Testing effectiveness (Phase 2)WithdrawnNCT01981811
What this trial is testing

Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder

Who this might be right for
Bipolar 1 DisorderSchizophreniaMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc.
Not applicableStudy completedNCT00468130
What this trial is testing

Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children

Who this might be right for
Autism
University of Medicine and Dentistry of New Jersey 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714213
What this trial is testing

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID-19 Condition (PCC or Long COVID)
Christiana Franke 138
Testing effectiveness (Phase 2)Study completedNCT00208533
What this trial is testing

Aripiprazole in Children With Autism: A Pilot Study

Who this might be right for
Autism
Drexel University College of Medicine 11
Large-scale testing (Phase 3)Study completedNCT00036101
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
Large-scale testing (Phase 3)Study completedNCT01001702
What this trial is testing

Oral Aripiprazole Open-Label Rollover Study

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 85
Post-approval studies (Phase 4)Study completedNCT00167817
What this trial is testing

Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study

Who this might be right for
Schizophrenia
Veterans Medical Research Foundation 15
Post-approval studies (Phase 4)WithdrawnNCT00728312
What this trial is testing

Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial

Who this might be right for
Methamphetamine Dependence
US Department of Veterans Affairs
Post-approval studies (Phase 4)Study completedNCT03376763
What this trial is testing

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Who this might be right for
SchizophreniaAntipsychoticsLong-Acting Injection+2 more
Korea Otsuka Pharmaceutical Co., Ltd. 201
Large-scale testing (Phase 3)Study completedNCT00095745
What this trial is testing

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,002
Large-scale testing (Phase 3)Study completedNCT01129882
What this trial is testing

An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 709
Next Page